Journey Medical Corp financials

  1. Home
  2. Financials
  3. DERM
DERM CIK 0001867066

Source: EDGAR filings · Built 2026-06-02T02:49:24Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021
Free Cash Flow — -24.13M 240.00K -33.53M — —
EBITDA — — — — -34.88M 7.86M
Working Capital 29.43M 13.00M 14.59M 10.85M 32.88M 7.18M
Net Debt 1.31M 4.78M -12.71M -4.05M -48.98M -8.06M
Gross Margin 65.83% 62.13% 61.63% 56.65% 49.18% 67.23%
Operating Margin -13.34% -24.81% -3.47% -38.76% -55.25% 17.63%
Net Margin -18.67% -26.61% -6.46% -41.73% -69.68% 11.86%
Return on Equity (ROE) -35.89% -73.11% -18.93% -174.47% -104.64% 51.33%
Return on Assets (ROA) -12.08% -18.28% -5.01% -28.17% -45.22% 10.18%
Current Ratio 1.79× 1.37× 1.35× 1.16× 1.64× 1.26×
Debt-to-Equity 0.80× 1.25× 0.72× 1.65× 0.00× 0.02×
Effective Tax Rate -0.53% -0.42% -6.08% -0.21% -3.86% 26.14%
Cash Conversion Ratio 1.09× 0.62× -1.36× 0.46× 0.05× 0.97×
Accruals Ratio 0.01× -0.07× -0.12× -0.15× -0.43× 0.00×
SBC % of Revenue 10.27% 11.06% 4.37% 6.23% 3.91% 0.34%
CapEx Coverage — -0.61× 1.05× -0.68× — —
Free Cash Flow Per Share — $-1.18 $0.01 $-1.91 — —

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021
P/FCF — — 436.36× — — —
FCF Yield — — 0.23% — — —
P/S 3.08× 1.45× 1.76× 0.47× 0.96× —
P/B 5.93× 3.98× 5.16× 1.98× 1.45× —

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021
Revenue from Contract with Customer, Excluding Assessed Tax 61.24M 55.13M 59.66M 71.00M 63.13M 44.53M
Revenues 61.86M 56.13M 79.18M 73.67M 63.13M —
Cost of Revenue 20.92M 20.88M 22.89M 30.77M 32.08M 14.59M
Research and Development Expense 480.00K 9.86M 7.54M 10.94M 2.74M —
Selling, General and Administrative Expense 44.37M 40.20M 43.91M 59.47M 39.83M 22.09M
Operating Income (Loss) -8.17M -13.68M -2.07M -27.52M -34.88M 7.85M
Income Tax Expense (Benefit) 60.00K 61.00K 221.00K 63.00K 1.63M 1.87M
Net Income (Loss) Attributable to Parent -11.43M -14.67M -3.85M -29.63M -43.99M 5.28M
Earnings Per Share, Basic $-0.47 $-0.72 $-0.21 $-1.69 $-4.32 $0.58
Weighted Average Number of Shares Outstanding, Basic 24.50M 20.43M 18.23M 17.53M 10.19M 9.14M
Earnings Per Share, Diluted $-0.47 $-0.72 $-0.21 $-1.69 $-4.32 $0.49
Weighted Average Number of Shares Outstanding, Diluted 24.50M 20.43M 18.23M 17.53M 10.19M 10.84M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021
Cash and Cash Equivalents, at Carrying Value 24.09M 20.30M 27.44M 32.00M 49.08M 8.25M
Assets, Current 66.87M 48.18M 56.45M 77.68M 84.49M 35.24M
Assets 94.59M 80.24M 76.85M 105.16M 97.28M 51.91M
Long-term Debt 25.28M 24.88M 14.62M 27.77M — —
Liabilities, Current 37.44M 35.17M 41.87M 66.83M 51.61M 28.06M
Long-term Debt, Excluding Current Maturities 25.28M 24.88M 14.62M 19.83M — —
Liabilities 62.74M 60.17M 56.50M 88.18M 55.24M 41.61M
Stockholders' Equity Attributable to Parent 31.85M 20.07M 20.35M 16.98M 42.04M 10.29M
Common Stock, Shares, Outstanding — — — — 11.32M 3.15M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021
Net Cash Provided by (Used in) Operating Activities -12.44M -9.13M 5.24M -13.53M -2.18M 5.13M
Net Cash Provided by (Used in) Investing Activities — -15.00M -5.00M -20.00M -10.00M -1.20M
Net Cash Provided by (Used in) Financing Activities 16.23M 16.99M -4.80M 16.46M 53.02M -487.00K

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (DERM CIK 0001867066), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

BTBT

BIT DIGITAL, INC.

JCI

JOHNSON CONTROLS INTERNATIONAL PLC

SIRI

SIRIUS XM HOLDINGS INC.